Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of DS-5058b and oxycodone hydrochloride in Japanese subjects
jRCT1080223737Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of oxycodone in pain (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoints: Cmax ratio (DS-5058b vs reference oxycodone) and 90% confidence interval and AUCall ratio (DS-5058b vs reference oxycodone) and 90% confidence interval. Started Nov 2017; status: completed.
02
Drugs
oxycodone
03
Conditions
pain
Beyond the preview
Go deeper on jRCT1080223737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223737.